StockNews.com assumed coverage on shares of Electromed (NYSE:ELMD – Get Rating) in a research note issued on Sunday. The brokerage set a “buy” rating on the stock.
Electromed Stock Performance
Electromed stock opened at $10.11 on Friday. Electromed has a 1 year low of $8.75 and a 1 year high of $13.84. The firm has a 50 day moving average price of $11.63 and a 200 day moving average price of $10.69. The company has a market cap of $86.04 million, a price-to-earnings ratio of 43.96 and a beta of 0.47.
Electromed (NYSE:ELMD – Get Rating) last released its earnings results on Tuesday, February 14th. The company reported $0.11 earnings per share (EPS) for the quarter. Electromed had a net margin of 4.76% and a return on equity of 6.05%. The firm had revenue of $11.73 million during the quarter.
About Electromed
Electromed, Inc engages in the development, manufacture, marketing, and sale of medical equipment. The firm’s products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers.
Featured Articles
- Get a free copy of the StockNews.com research report on Electromed (ELMD)
- MarketBeat Week in Review – 3/13 – 3/17
- This Small Tech With Big Growth Prospects Is Nearing A Buy Point
- Don’t Chase FedEx Higher, Wait For The Pullback
- 3 Stocks For A Defensive Tech Portfolio
- Milk the Dividends on These 3 Cash Cows
Receive News & Ratings for Electromed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Electromed and related companies with MarketBeat.com's FREE daily email newsletter.
